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Abstract 16 
This study aimed to investigate the effects of long chain fatty acids (α-linolenic acid; 17 
ALA, docosahexaenoic acid; DHA, eicosapentaenoic acid; EPA, linoleic acid; LA, 18 
oleic acid; OA and palmitic acid; PA) at concentrations of 10-100 µM, on extended 19 
bull sperm stored in vitro, for up to 7 days. Progressive linear motion (PLM), viability 20 
(Experiments 1-3), ability to penetrate artificial mucus (Experiment 1), reactive 21 
oxygen species (ROS; Experiment 2) and superoxide production (Experiment 3) were 22 
assessed. Sperm maintained the ability to penetrate artificial mucus up to Day 4, 23 
irrespective of treatment. In Experiments 2 and 3, DHA and EPA had detrimental 24 
effects on PLM and viability. PA preserved PLM and viability at levels greater than 25 
the control (P < 0.05), while sustaining ROS levels to a minimum, particularly on 26 
Days 1 and 3 (P < 0.01) when ROS generation peaked in other treatments. In contrast, 27 
superoxide production peaked on Day 0 (Experiment 3), and declined thereafter with 28 
no significant effect of fatty acid. This study supports the notion that superoxide 29 
dominates on Day 0, while its breakdown products from its reactions, hydrogen 30 
peroxide and the hydroxyl radical as assessed by CM-H2DCFDA, contribute to ROS 31 
generation on subsequent days.  32 
 33 
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1. Introduction  37 
Polyunsaturated fatty acids (PUFAs) have been widely reported, in both human and 38 
animal models, to have beneficial effects on the cardiovascular (Bønaa et al., 1990) 39 
and nervous (Alessandri et al., 2004; Brenna and Diau, 2007) systems. In more recent 40 
years, there has been an increased focus on the role of PUFA’s on female fertility 41 
(Childs et al., 2008; Hammiche et al., 2010) and to a lesser extent, male fertility 42 
(Wathes et al., 2007). In the case of male fertility, the main focus of this work has 43 
either been on the inclusion of specific fatty acids in the diet as reviewed by 44 
(Comhaire and Mahmoud, 2003) and on the comparison of the lipid profile of sperm 45 
between fertile and infertile males (Aksoy et al., 2006; Safarinejad et al., 2010). 46 
 47 
Supplementation with dietary fish oils, rich in long chain fatty acids, has been 48 
demonstrated to successfully modify the fatty acid profile of the plasma and sperm 49 
across a range of species (Kelso et al., 1997a; Comhaire et al., 2000; Rooke et al., 50 
2001; Castellano et al., 2010; Gholami et al., 2010), however, it is still unclear if this 51 
has a beneficial effect on sperm cell function. An increase in the proportion of n-3 52 
fatty acids in ejaculated boar sperm led to the number of progressively motile cells 53 
being increased after being fed with tuna oil (Rooke et al., 2001), however, others 54 
found no beneficial effects in terms of semen production (Castellano et al., 2010), the 55 
lifespan of extended sperm stored at 17 
o
C or following cryopreservation  (de Graaf et 56 
al., 2007; Castellano et al., 2010). Furthermore, supplementation of n-3, 57 
docosahexaenoic acid in the diet was found to improve motility, velocity and the 58 
viability of extended Holstein bull sperm, while it had no effect on frozen sperm 59 
(Gholami et al., 2010). 60 
 61 
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The fatty acid profile of normal and abnormal human sperm has recently been 62 
investigated. Koppers et al. (2010) reported that defective human spermatozoa contain 63 
more total fatty acids {saturated fatty acids (SFA), monounsaturated fatty acids 64 
(MUFA) and PUFAs} than functional sperm and those in the fatty acid pool of 65 
defective sperm contain a high proportion of PUFA’s such as DHA. They 66 
hypothesised that this was due to a failure in the functional remodelling of the sperm 67 
plasma membrane during epididymal transit where these fatty acids are normally lost. 68 
An abnormally low concentration of unsaturated fatty acids would be expected to 69 
reduce the fluidity of the membrane (Lenzi et al., 2000; Aksoy et al., 2006) while 70 
superabundance of unsaturated fatty acids would expose sperm to attack by reactive 71 
oxygen species (ROS) generated by the sperm mitochondria (Aitken et al., 2006).  72 
 73 
In vitro models provide an opportunity to study the effect of exogenous fatty acids on 74 
sperm cell function using a wide range of in vitro parameters. It has been reported that 75 
fatty acids were incorporated into the lipids of sperm cell membranes within two 76 
hours of the addition to cell cultures (Neill and Masters, 1971). In human sperm, the 77 
in vitro addition of unsaturated fatty acids (arachidonic, linoleic, docosahexaenoic, 78 
palmitoleic and oleic) has been shown to dramatically increase the number of sperm 79 
testing positive for ROS, however, the addition of saturated fatty acids (palmitic and 80 
stearic) did not (Aitken et al., 2006; Koppers et al., 2010). In contrast, motility, 81 
viability and acrosome reaction levels were all improved after the in vitro addition of 82 
exogenous unsaturated fatty acids (oleic and linoleic, combination of oleic and 83 
arachidonic increased acrosome reaction) to extended boar sperm (Hossain et al., 84 
2007) while the viability of extended bull sperm was maintained for longer after the 85 
addition of short chain fatty acids (Shannon, 1962).  86 
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 87 
There is limited published work on the effect of the aforementioned long chain 88 
unsaturated fatty acids on the functional capacity of stored bull sperm. The objectives 89 
of the present study were to investigate the effect of the in vitro addition of a range of 90 
exogenous unsaturated fatty acids on motility, viability, ability to penetrate artificial 91 
mucus and the generation of ROS.   92 
 93 
2. Materials and Methods 94 
2.1 Animal and Semen Processing 95 
Semen was collected in a commercial artificial insemination (AI) centre from three 96 
bulls of proven fertility in each replicate of each experiment. A fraction of each 97 
ejaculate (0.2 mL) from the 3 bulls was pooled and diluted in 4 mL of appropriate 98 
semen diluent. Following transport at 37 °C to the laboratory within 1 h of collection, 99 
the sperm concentration was assessed using a haemocytometer and diluted to a final 100 
concentration of 40 x 10
6
 sperm/mL. Diluted semen (1 mL/treatment) was stored in an 101 
eppendorf at 5 ˚C in the presence of the relevant fatty acids (as described below) for 4 102 
days (Experiment 1) or 7 days (Experiments 2 and 3).  103 
 104 
2.2 Experimental Design 105 
2.2.1 Experiment 1 106 
The aim of this experiment was to examine the effect of exogenous fatty acids on the 107 
subsequent ability of stored bull sperm to penetrate artificial mucus in vitro. Semen 108 
was diluted in an egg-yolk based diluent {Sodium Citrate (63 mM); Glycine (124 109 
mM); Glucose (1.5 M); Glycerol solution (1.14% v/v); Penicillin g sodium (1163 U); 110 
Catalase solution (17.14 U}; Citric acid (0.7 mM), 5% v/v egg yolk, pH 7.4) in the 111 
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presence of eicosapentaenoic acid (EPA; C20:5, n-3), α-linolenic acid (ALA; C18:3, 112 
n-3) or palmitic acid (PA; C16:0, Saturated fat) at concentrations of 0, 10, 50 and 100 113 
µM. As the fatty acids were dissolved in ethanol, a 0.096 % ethanol control was 114 
included (vehicle control) as this was the highest final concentration of ethanol in any 115 
treatment. As a quality control and to account for day to day variation a pool of 116 
frozen-thawed sperm from 3 bulls of proven field fertility were included on each day 117 
of analysis (results not shown). All treatments were assessed on Days 0, 1, 2, 3 and 4 118 
for progressive linear motion (PLM), viability and ability to penetrate artificial mucus. 119 
Four replicates were completed.  120 
 121 
2.2.2 Experiment 2 122 
The aim of this experiment was to examine the effect of the addition of fatty acids to 123 
extended bull sperm stored for up to 7 days on the generation of ROS. Semen was 124 
diluted in a citrate based diluent without egg yolk {Sodium Citrate (75.5 mM); 125 
Glycine (130.6 mM); Glucose (16.3 mM); Glycerol solution (1.23% v/v); Penicillin g 126 
sodium (1225 U); Catalase solution (17.14 U); Citric acid (0.7 mM); pH 7.4} in the 127 
presence of EPA, ALA, PA, linoleic acid (LA; C18:2, n-6), oleic acid (OA; C18:1, n-128 
9) or docosahexaenoic acid (DHA; C22:6, n-3) at concentrations of 0, 10 and 100 µM. 129 
Egg yolk was not included in the media for Experiment 2 due to its potential 130 
compromising effects from its fatty acid content. Controls as per Experiment 1 were 131 
included and all treatments were assessed on Days 0, 1, 3 and 7 for PLM, viability and 132 
generation of ROS. Viability and ROS were assessed using flow cytometry and the 133 
fluorescent probes Propidium Iodide (PI, Invitrogen; P1304MP) and Chloromethyl-134 
2,7-dichlorofluorescein diacetate (CM-H2DCFDA; Invitrogen, C6827), respectively. 135 
CM-H2DCFDA is a general intra-cellular stain which fluoresces green in the presence 136 
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of the ROS, namely, hydrogen peroxide (H2O2), hydroxyl radical (OH·), peroxyl 137 
radical (ROO·) and the peroxynitrite anion (ONOO
-
). Four replicates were completed.  138 
 139 
2.2.3 Experiment 3 140 
The aim of this experiment was to examine the effect of the addition of exogenous 141 
fatty acids to extended bull sperm on the mitochondrial generation of the superoxide 142 
anion. Semen was diluted in a citrate based diluent and stored in the presence of the 143 
same fatty acid treatments as Experiment 2. All treatments were assessed on Days 0, 144 
1, 3 and 7 for PLM, viability and generation of superoxide. Viability and superoxide 145 
anion were assessed using flow cytometry and the fluorescent probes SYTOX Green 146 
(Invitrogen, S7020) and MitoSOX Red (Invitrogen, M36008), respectively. MitoSOX 147 
Red is an intra-cellular stain which fluoresces red in the presence of the superoxide 148 
anion (·O2
-
). Four replicates were completed. 149 
 150 
2.3 Progressive Linear Motion and Viability 151 
PLM was assessed for each treatment by placing a 5 µL sample on a pre-warmed slide 152 
and assessing 100 live cells, on a scale from 0 to 100 (0 indicating no progressive 153 
linear motion observed among the live cells, 100 indicating 100% of live cells were 154 
moving in a progressive linear motion). In Experiment 1, sperm viability was 155 
examined using a nigrosin-eosin stain (0.068 M water soluble nigrosin; 0.014 M water 156 
soluble eosin; 0.116 M sodium citrate). A sample of sperm (50 µL) from each 157 
treatment was added to nigrosin-eosin stain, in a 1:1 ratio. This was incubated at 37 158 
°C for 30 sec following which a smear was prepared on a glass slide and allowed to 159 
dry on a heated stage at 37 °C. Sperm were viewed under a phase contrast microscope 160 
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(40X) and an average of three counts were taken, where 100 sperm were assessed in 161 
each count.  162 
 163 
2.4 Mucus Penetration Test 164 
The mucus penetration test was performed as per Al Naib et al. (2011a) with minor 165 
adaptions. Briefly, artificial mucus (sodium hyaluronate based, MAP-5, Labstock 166 
MicroServices, Ireland) was diluted in phosphate buffered saline (PBS) to a final 167 
concentration of 6 mg sodium hyualuronate/mL. Flattened capillary tubes, marked at 168 
10, 30 and 70 mm intervals, were loaded with artificial mucus and 1 tube was placed 169 
vertically in a 1.5 mL Eppendorf, representing a treatment. Each Eppendorf contained 170 
250 µL of sperm diluted to 20 × 10
6 
sperm/mL in Biggers, Whitten and Whittingham 171 
media {BWW; Koppers et al. (2008)} (Fatty Acid Free bovine serum albumin used 172 
instead of polyvinyl alcohol, pH 7.4). Samples were incubated for 10 min in a dry 173 
oven at 37 
o
C, following which; the capillary tubes were placed on a hot plate at 50◦C 174 
for 30 sec followed by 3 min at 4 
o
C in order to kill and immobilise the sperm cells. 175 
At each mark along the tube (10, 30, 70 mm), sperm were counted using a fluorescent 176 
microscope (Olympus BX 60) in one field of view wide (40X), wall to wall across the 177 
tube. The total number of sperm at each mark in each tube were combined for 178 
subsequent analysis.  179 
 180 
2.5 Measurement of ROS (CM-H2DCFDA) 181 
A representative sample from each treatment (100 µL) was added to 10 mL of filtered 182 
PBS (pH 7.4) followed by centrifugation at 800 g for 10 min at 32 °C. Following 183 
removal of the supernatant, sperm concentration of the pellet was assessed using a 184 
haemocytometer, and the sample was diluted to 1.2 × 10
6
 sperm/mL in pre-warmed 185 
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PBS (367 µL). CM-H2DCFDA (50 µL) was added to give a final working 186 
concentration of 100 µM and samples were incubated for 30 min in a dry oven at 37 187 
°C. PI (83 µL) was added to each of the samples to give a final working concentration 188 
of 50 µM and samples were incubated for a further 15 min. Samples were 189 
subsequently washed in 5 mL PBS by centrifugation at 800 g for 10 min at 32 °C.  190 
Fluorescent labelled sperm were analysed using a Becton Dickinson (BD Biosciences, 191 
San Jose, California, USA) LSR I flow cytometer. The 488 Ar-Ion laser was used to 192 
excite both stains, with the FL1 detector reading CM-H2DCFDA (Ex/Em 502/523 193 
nm) and the FL2 detector reading PI (Ex/Em 535/617 nm). A suitable protocol were 194 
established by running relevant controls to set gates, detectors and voltages, while all 195 
data were read on the log scale. A total of 10,000 events were recorded with a flow 196 
rate of approx 150 events per second and data were analysed on Cell Quest 3.7. Cells 197 
producing general ROS (i.e. positive for CM-H2DCFDA) were gated and results are 198 
displayed as a percentage of the total live cells in the population. 199 
  200 
2.6 Measurement of Superoxide (MitoSOX Red) 201 
A representative sample (100 µL) from each treatment was added to 10 mL of filtered 202 
BWW (pH 7.4) and centrifuged at 800 g for 10 min at 32 °C.  Following removal of 203 
the supernatant, sperm concentration was assessed and diluted to 1.2 × 10
6
 sperm/mL 204 
in a 472.5 µL of BWW. MitoSOX Red stock (25 µL) was added to each sample to 205 
give a final working concentration of 2.5 µM and samples were incubated for 15 min 206 
in a dry oven at 37 °C. At the end of the incubation period SYTOX Green (2.5 µL) 207 
was added to give a final working concentration of 0.25 µM following which samples 208 
were incubated for a further 15 min. Samples were then washed in 5 mL BWW, 209 
centrifuged at 800 g for 10 min at 32 °C and were analysed on a Becton Dickinson 210 
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LSRI flow cytometer, as per Experiment 2. The 488 Ar-Ion laser was used to excite 211 
both stains, with the FL1 detector reading SYTOX Green (Ex/Em 504/523 nm) and 212 
the FL2 detector reading MitoSOX Red (Ex/Em 510/580 nm). Cells producing 213 
superoxide (i.e. positive for MitoSOX Red) were gated and results are displayed as a 214 
percentage of the total live cells in the population. 215 
 216 
2.7 Statistical Analysis 217 
All analyses were carried out using the SAS v9.1.3 software package (SAS Institute, 218 
Cary, NC, USA) (SAS/STAT. 2000). Diagnostic tests were used to determine if data 219 
had a normal distribution and data that did not approach a normal distribution were 220 
transformed using a box-cox transformation (Box and Cox, 1964) in order to meet the 221 
assumptions of analysis of variance.  222 
 223 
Data presented in this paper shows the non-transformed values of the data, however, 224 
all P-values were calculated using the transformed data where required. Data were 225 
analysed using a repeated measures model for day that included the fixed effects of 226 
day, fatty acid, concentration of fatty acid, all two way interactions, and the three-way 227 
interaction of the fixed effects, where appropriate. Effects with a P-value <0.25 were 228 
retained in the model. Repeated measures for day were fitted using the appropriate 229 
covariance function as determined by the Bayesian Information Criterion, and the 230 
Tukey adjustment was used for multiple comparisons. Statistical differences were 231 
reported when P-values were < 0.05. Results are reported as least square means ± 232 
s.e.m unless otherwise stated. 233 
 234 
3. Results 235 
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3.1 Experiment 1 236 
PLM and % live declined in all treatments over the five days (P < 0.01). There was an 237 
effect of fatty acid on PLM (P < 0.05), with the 100 μM EPA treatment showing the 238 
lowest PLM score on Day 4 compared to Day 0 (66.4 ± 3.53% and 90.0 ± 3.10%, 239 
respectively; (P < 0.001). Irrespective of concentration, all PA treatments had higher 240 
PLM values on Day 4 compared to the control, (87.8 ± 3.10%, 84.4 ± 3.53%, 75.4 ± 241 
3.53% for the 10, 50 and 100 μM PA treatments vs 72.4 ± 3.53% for the control) but 242 
only the 50 μM PA treatment reached significance (P < 0.05). In contrast, all EPA 243 
treatments show lower PLM values on Day 4 compared to the control (69.4 ± 3.53%, 244 
69.4 ± 3.53% and 66.4 ± 3.53% for the 10, 50 and 100 µM EPA treatments vs 72.4 ± 245 
3.53% for the control). Only 50 μM ALA and 50 μM PA treatments showed 246 
significantly higher numbers of live sperm compared to the control on Day 4 (ALA 247 
75.5 ± 5.70%; PA 78.1 ± 5.88% and Control 68.8 ± 5.88%). There was no significant 248 
effect of fatty acid, concentration, day or their interaction on the ability of sperm to 249 
penetrate artificial mucus (Figure 1). However, irrespective of treatment, sperm 250 
retained the ability to penetrate mucus up to and including Day 4 (Control: 124.9 ± 251 
61.55% to 225.5 ± 70.55%; 10 µM ALA: 170.0 ± 61.55% to 170.0 ± 70.55; 100 µM 252 
EPA: 166.8 ± 61.55% to 125.3 ± 70.55% and 10 µM PA: 120.1 ± 61.55 to 173.0 ± 253 
70.55%, Day 0 and Day 4 values, respectively ).  254 
 255 
3.2 Experiment 2 256 
PLM decreased over time in all treatments (P < 0.01), but the most dramatic decline 257 
was in the EPA and DHA treatments with PLM declining more rapidly in the 100 µM 258 
compared to the 10 µM treatments in both cases up to Day 3 (P < 0.05). PLM in the 259 
100 µM DHA treatment on Days 0 and 1 were 69.8 ± 5.51% and 22.5 ± 5.51%, 260 
12 
 
respectively. PA (100 µM) and OA (10 and 100 µM) maintained the highest PLM up 261 
to and including Day 7 (45.0 ± 6.39%; 27.0 ± 6.39% and 24.0 ± 6.39%, respectively) 262 
in comparison to the control, which contained no progressively motile sperm on Day 263 
7 (P < 0.01).  264 
 265 
Similarly to PLM, viability declined over time (P < 0.05; except 10 µM OA). The 266 
proportion of viable sperm ranged from 67.0 ± 6.05% to 36.7 ± 6.05% (100 µM OA 267 
and 100 µM EPA, respectively) on Day 0 and from 45.6 ± 6.97% to 4.08 ± 6.97% 268 
(100 µM PA and 100 µM DHA, respectively) on Day 7. The most rapid decline was 269 
in both the 10 and 100 µM EPA and DHA treatments. In the 100 µM EPA treatment 270 
viability decreased from 36.7 ± 6.05% on Day 0 to 26.7 ± 6.05 on Day 1 (P < 0.01) 271 
while in the 100 µM DHA treatment on Day 0 and 1, viability decreased from 49.0 ± 272 
6.05% to 28.0 ± 6.05%, respectively (P < 0.05). Interestingly, even though 100 µM 273 
EPA and DHA treatments had the lowest number of viable sperm on Days 1, 3 and 7 274 
(100 µM EPA: 27.6 ± 6.05%; 14.0 ± 6.05% and 4.6 ± 6.97%, 100 µM DHA: 28.0 ± 275 
6.05%; 15.0 ± 6.05% and 4.1 ± 6.97%, respectively), both fatty acids at 10 µM 276 
maintained a higher sperm cell viability compared to their 100 µM counterparts on all 277 
Days (DHA; P < 0.01, EPA; P < 0.05). Consistent with the PLM test, OA (10 and 100 278 
µM), ALA (10 µM) and PA had the greatest ability to maintain viability, with a score 279 
for each on Day 7 of 45.6 ± 6.97%, 39.1 ± 6.97%, 44.6 ± 6.97% and 45.6 ± 6.97 %, 280 
respectively. The control had a viability score of 64.0 ± 6.05% and 20.0 ± 6.97% on 281 
Day 0 and 7, respectively. These results suggest that DHA and EPA (100 µM in both 282 
fatty acids) are cytotoxic to sperm cells.  283 
 284 
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There was an effect of Day on ROS production (P < 0.0001) where ROS generation 285 
peaked on either Day 1 or Day 3 dependent on treatment (Figure 2). The number of 286 
live sperm positive for ROS was highest in the 100 µM LA, 10 µM EPA and 100 µM 287 
OA treatments on Day 1 (68.6 ± 10.04%; 69.4 ± 10.04% and 67.9 ± 10.04%, 288 
respectively) and in the 10 µM OA, 100 µM OA and 10 µM ALA treatments on Day 289 
3 (76.9 ± 10.04%; 73.9 ± 10.04% and 73.3 ± 10.04%, respectively; Figure 2). The 290 
level of ROS in the control treatment reached a peak of 67.5 ± 10.04% on Day 1 and 291 
declined thereafter. PA displayed an inherent ability to maintain levels of ROS in 292 
viable sperm to a minimum compared to the control on Days 1 and 3 (P < 0.01). On 293 
Day 1, most treatments showed a lower level of ROS compared to the control (67.5 ± 294 
10.04%), as only 100 µM LA, 10 µM EPA and 100 µM OA were higher (68.6 ± 295 
10.04%; 69.4 ± 10.04% and 67.9 ± 10.04%, respectively). On Day 7 ROS generation 296 
from live sperm was highest in the 10 µM LA (68.8 ± 11.63%, P < 0.05) and ALA 297 
(59.7 ± 11.63%, P < 0.05) and 10 and 100 µM OA (68.2 ± 11.63% and 43.6 ± 298 
11.63%, respectively) compared to the control (12.0 ± 11.63%).  299 
 300 
3.3 Experiment 3 301 
PLM decreased with time in all treatments (P < 0.01), but similar to Experiment 2 the 302 
most dramatic decline in PLM was in the EPA and DHA treatments (10 and 100 µM 303 
in both) which had lower PLM scores on Day 7 compared to the control (3.8 ± 304 
11.27%; 6.4 ± 13.10%; 0.0 ± 17.46%, Control: 13.2 ± 13.10%). PA maintained the 305 
highest PLM score up to Day 3 (78.8 ± 10.23%), but declined on Day 7. ALA (100 306 
µM) and OA (both 10 and 100 µM) had the highest PLM on Day 7. There was a 307 
significant effect of day on sperm cell viability; where viability declined in all 308 
treatments over the course of seven days (P < 0.01). The proportion of viable sperm 309 
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ranged from 67.5 ± 4.51% to 53.5 ± 4.51% (control and 10 µM ALA, respectively) on 310 
Day 0 and from 30.8 ± 4.51% to 5.3 ± 4.51% (10 µM ALA and 100 µM DHA, 311 
respectively) on Day 7. PA had the highest number of live sperm on Day 7 (34.5 ± 312 
4.51%) in comparison to all the other treatments including the control. Consistent 313 
with Experiment 2, 100 µM EPA and DHA had a significantly lower number of live 314 
sperm on Day 7 compared to the control (16.6 ± 4.87%, 5.3 ± 4.51% and 26.8 ± 315 
4.51%, respectively; P < 0.05). 316 
 317 
There was an effect of day on superoxide production (P < 0.0001) where the 318 
production of superoxide peaked on Day 0 (except 10 µM EPA) with all treatments 319 
having in excess of 72.7 ± 9.55% live sperm staining positive for superoxide (Figure 320 
3). Superoxide levels remained greater than 59.7 ± 9.55% (value of 10 µM ALA) in 321 
all treatments of Day 1 and declined thereafter, however, the rate of decline was not 322 
dependent on treatment. Superoxide production in the 100 µM DHA treatment 323 
remained high on Day 3 (59.6 ± 10.80%) compared to the other fatty acid treatments 324 
and the control (54.3 ± 9.55%). 325 
 326 
4. Discussion 327 
This is the first published study which has evaluated the effect of the in vitro addition 328 
of exogenous fatty acids on artificial mucus penetration and oxidative stress in 329 
extended bull sperm. The main findings were that while PLM and viability decreased 330 
with duration of storage, sperm cells maintained their ability to penetrate artificial 331 
mucus up to and including Day 4 (Experiment 1). ROS generation peaked on Days 1 332 
to 3 (Experiment 2) and declined thereafter, with OA and ALA showing a delay in the 333 
peak of ROS production, while PA maintained ROS levels at basal levels over all 334 
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days in comparison to the control. DHA and EPA proved to be detrimental to both 335 
PLM and viability (Experiment 2). While there was no significant effect of fatty acid 336 
on superoxide production (Experiment 3), interestingly its production peaked on Day 337 
0 and declined afterwards.  338 
 339 
While PLM and viability did decrease significantly with incubation time (Experiment 340 
1), there was no effect of time on the ability of sperm to penetrate artificial mucus, up 341 
to and including Day 4. This is in contrast to a recent study that demonstrated that 342 
after 2 days in storage, the ability of sperm cells to penetrate artificial mucus was 343 
significantly decreased (Al Naib et al., 2011b). In addition, there was no effect of 344 
fatty acid on the ability of sperm to penetrate artificial mucus in comparison to the 345 
control. It is postulated that the lack of effect could be attributed to the egg yolk based 346 
diluent used in Experiment 1 given the high proportion of lipids in egg yolk 347 
potentially interacting with the sperm membrane.  348 
 349 
DHA and EPA were detrimental to the PLM and viability of the sperm cells 350 
(Experiments 2 and 3), where higher concentrations of these long chain fatty acids 351 
caused a more rapid decline in both parameters. DHA has been reported to be the 352 
most abundant unsaturated fatty acid in ejaculated bull sperm (Kelso et al., 1997b), 353 
while poor quality human sperm cells had a significantly lower amount of DHA than 354 
normal cells (Koppers et al., 2010). In agreement with the current study, Koppers et 355 
al. (2010) reported a significant decrease in PLM and viability of human sperm cells 356 
following a 24 h incubation with 10 µM DHA. Aitken et al. (2006) stimulated ROS 357 
production with the short term exposure (15 min) of human sperm to 10 µM DHA 358 
while exposure to 115 µM DHA was cytotoxic to the sperm cells. In addition to this, 359 
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in human sperm DHA has been reported to be more susceptible to peroxidation than 360 
other PUFAs, such as arachidonic acid (Lukiw and Bazan, 2008; Oborna et al., 2010) 361 
and the in vitro addition of highly unsaturated fatty acids, like DHA, increases the 362 
amount of ROS formed by human sperm (Aitken and Baker, 2006). In the current 363 
study, EPA had similar effects on PLM and viability as DHA. It was noted however, 364 
that 10 µM EPA was not as detrimental as 10 µM DHA on PLM and viability. To the 365 
best of our knowledge this the first report of the effects of EPA on bull sperm in vitro. 366 
 367 
In general, ALA, OA and PA maintained PLM and viability up to and including Day 368 
7 (Experiment 2). In the ALA and OA treatments ROS generation peaked on Day 3, 369 
compared to Day 1 in the control. Interestingly, PA maintained ROS at the lowest 370 
levels on all days, corresponding to its good viability and PLM scores (as well as 371 
rapid movement; data not shown). PA is the most prominent saturated fatty acid in 372 
bull and human sperm fractions (Kelso et al., 1997b; Lenzi et al., 2000), while OA 373 
has a high representation in both these models. Neill and Masters (1971) demonstrated 374 
that fatty acids added in vitro, are incorporated into the membrane of the sperm cell. 375 
Thus, it is likely that the incorporation of PA (no double bonds) or OA (one double 376 
bond) into the sperm membrane would reduce the cells susceptibility to attack by 377 
ROS. Our findings are supported by Aitken et al. (2006) who demonstrated that short 378 
term exposure of human sperm to PA had no effect on ROS generation.  379 
 380 
Poor quality human spermatozoa have been demonstrated to have higher levels of 381 
unsaturated fatty acids than normal sperm cells (Ollero et al., 2001) and Cocco et al. 382 
(1999) suggested that these PUFAs could inhibit specific complexes of the 383 
mitochondrial electron transport carrier system, consequently causing the leakage of 384 
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electrons, followed by superoxide formation. It is for this reason that excessive 385 
generation of superoxide is a key indicator of poor, defective sperm (De Iuliis et al., 386 
2006) and has been reported to be one of the principal ROS generated by sperm cells 387 
(Lenzi et al., 1996). The current study would support this as greater than 71.7% of 388 
live sperm were positive for the superoxide anion on Day 0. This coupled with the 389 
findings in Experiment 2 would indicate that bull sperm stored in vitro are subject to 390 
the greatest oxidative stress early in the storage period, on Day 0 from superoxide and 391 
on Days 1 and 3 from other oxidising free radicals, including the hydroxyl radical and 392 
hydrogen peroxide. It has been demonstrated that superoxide (·O2
-
) can gain a proton 393 
to quickly form the hydroperoxyl (HO2) radical (Kothari et al., 2010) or can generate 394 
hydrogen peroxide spontaneously or after activity of superoxide dismutase (Alvarez et 395 
al., 1987). Following this, in the presence of hydrogen peroxide and excess 396 
superoxide, hydroxyl radicals can be formed via the Haber Weiss reaction (Aitken et 397 
al., 1989). Thus, we hypothesise that the superoxide anion dominates on Day 0, and 398 
its breakdown products then form other ROS such as the hydroperoxyl radical, 399 
hydrogen peroxide and the hydroxyl radical in subsequent days. Even though PA 400 
maintained levels of ROS at basal levels in Experiment 2, it had no effect on 401 
superoxide production nor did any of the other fatty acid treatments. (Koppers et al., 402 
2010) reported that saturated fatty acids did not effect the generation of superoxide, 403 
however, they demonstrated that a high percentage of functional human sperm cells 404 
were live and positive for superoxide after 15 min exposure to unsaturated fatty acids 405 
(DHA, LA, AA and OA) at 10 µM.  406 
 407 
In conclusion, this study has identified that in extended bull sperm superoxide 408 
production peaks on Day 0 and its breakdown products contribute to ROS generation 409 
18 
 
on subsequent days. The addition of DHA and EPA to bull sperm in vitro has 410 
detrimental effects on PLM and viability, while the addition of PA and OA maintains 411 
both of these parameters. These differences may be explained by the ability of PA and 412 
OA to minimise or delay the production of ROS. 413 
 414 
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 559 
Figure 1: The ability of sperm stored with ALA, EPA (both n-3) and PA (SFA) at 560 
concentrations of 10, 50 and 100 µM to penetrate artificial mucus. Each treamtment 561 
was assessed on Days 0, 1, 2, 3 and 4. A vehicle control was included (n = 4 562 
replicates) 563 
564 
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 566 
Figure 2: Generation of Reactive Oxygen Species (ROS) by viable sperm stored with 567 
ALA, DHA, EPA (all n-3), LA (n-6) or OA (n-9) at concentrations of 10 and 100 µM 568 
assessed on Days 0, 1, 3 and 7. Both a saturated fat control (PA) and a vehicle control 569 
were included; vertical bars represent s.e.m (n = 4 replicates) 570 
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 572 
 573 
Figure 3: Generation of Superoxide by viable sperm stored with ALA, DHA, EPA 574 
(all n-3), LA (n-6) or OA (n-9) at concentrations of 10 and 100 µM assessed on Days 575 
0, 1, 3 and 7. Both a saturated fat control (PA) and a vehicle control were included; 576 
vertical bars represent s.e.m (n = 4 replicates) 577 
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